ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Giardia Diagnostic Test Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-22Z16961
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Giardia Diagnostic Test Kit Market Research Report 2024
BUY CHAPTERS

Global Giardia Diagnostic Test Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-22Z16961
Report
November 2025
Pages:180
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
FastEST
Cardinal Health
Anigen
ALLTEST
Bioguard Corporation
Bionote
Coris BioConcept
Fassisi
IDEXX Laboratories
MEGACOR Diagnostik
Nanjing Liming Bio-products Co., Ltd.
R-Biopharm AG
VIDIA s.r.o
Wuhan J.H.Bio-Tech
Equi
HWTA

Giardia Diagnostic Test Kit Market

The global Giardia Diagnostic Test Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Pet Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Giardia Diagnostic Test Kit leading manufacturers including Certest Biotec, FASTest, Cardinal Health, Thermo Fisher Scientific, Anigen, ALLTEST, Bioguard corporation, Bionote, Coris BioConcept, Equi, etc., dominate supply; the top five capture approximately % of global revenue, with Certest Biotec leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Giardia Diagnostic Test Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Giardia Diagnostic Test Kit Market Report

Report Metric Details
Report Name Giardia Diagnostic Test Kit Market
Segment by Type
  • For Human
  • For Pets (Cats Or Dogs)
Segment by Application
  • Pet Hospital
  • Pharmacy
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Certest Biotec, FASTest, Cardinal Health, Thermo Fisher Scientific, Anigen, ALLTEST, Bioguard corporation, Bionote, Coris BioConcept, Equi, Fassisi GmbH, HWTA, Idexx Laboratories, MEGACOR Diagnostik, Nanjing Liming Bio-products Co., Ltd., R-Biopharm AG, VIDIA s.r.o, Wuhan J.H.Bio-Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Giardia Diagnostic Test Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Giardia Diagnostic Test Kit Market report?

Ans: The main players in the Giardia Diagnostic Test Kit Market are Certest Biotec, FASTest, Cardinal Health, Thermo Fisher Scientific, Anigen, ALLTEST, Bioguard corporation, Bionote, Coris BioConcept, Equi, Fassisi GmbH, HWTA, Idexx Laboratories, MEGACOR Diagnostik, Nanjing Liming Bio-products Co., Ltd., R-Biopharm AG, VIDIA s.r.o, Wuhan J.H.Bio-Tech

What are the Application segmentation covered in the Giardia Diagnostic Test Kit Market report?

Ans: The Applications covered in the Giardia Diagnostic Test Kit Market report are Pet Hospital, Pharmacy

What are the Type segmentation covered in the Giardia Diagnostic Test Kit Market report?

Ans: The Types covered in the Giardia Diagnostic Test Kit Market report are For Human, For Pets (Cats Or Dogs)

1 Study Coverage
1.1 Introduction to Giardia Diagnostic Test Kit: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Giardia Diagnostic Test Kit Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 For Human
1.2.3 For Pets (Cats Or Dogs)
1.3 Market Segmentation by Application
1.3.1 Global Giardia Diagnostic Test Kit Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pet Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Giardia Diagnostic Test Kit Revenue Estimates and Forecasts 2020-2031
2.2 Global Giardia Diagnostic Test Kit Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Giardia Diagnostic Test Kit Sales Estimates and Forecasts 2020-2031
2.4 Global Giardia Diagnostic Test Kit Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Giardia Diagnostic Test Kit Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Giardia Diagnostic Test Kit Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 For Human Market Size by Manufacturers
3.5.2 For Pets (Cats Or Dogs) Market Size by Manufacturers
3.6 Global Giardia Diagnostic Test Kit Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Giardia Diagnostic Test Kit Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Giardia Diagnostic Test Kit Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Giardia Diagnostic Test Kit Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Giardia Diagnostic Test Kit Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Giardia Diagnostic Test Kit Sales and Revenue by Type (2020-2031)
6.4 North America Giardia Diagnostic Test Kit Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Giardia Diagnostic Test Kit Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Giardia Diagnostic Test Kit Sales and Revenue by Type (2020-2031)
7.4 Europe Giardia Diagnostic Test Kit Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Giardia Diagnostic Test Kit Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Giardia Diagnostic Test Kit Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Giardia Diagnostic Test Kit Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Giardia Diagnostic Test Kit Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Giardia Diagnostic Test Kit Sales and Revenue by Type (2020-2031)
9.4 Central and South America Giardia Diagnostic Test Kit Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Giardia Diagnostic Test Kit Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Giardia Diagnostic Test Kit Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Giardia Diagnostic Test Kit Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Giardia Diagnostic Test Kit Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Certest Biotec
11.1.1 Certest Biotec Corporation Information
11.1.2 Certest Biotec Business Overview
11.1.3 Certest Biotec Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.1.4 Certest Biotec Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Certest Biotec Giardia Diagnostic Test Kit Sales by Product in 2024
11.1.6 Certest Biotec Giardia Diagnostic Test Kit Sales by Application in 2024
11.1.7 Certest Biotec Giardia Diagnostic Test Kit Sales by Geographic Area in 2024
11.1.8 Certest Biotec Giardia Diagnostic Test Kit SWOT Analysis
11.1.9 Certest Biotec Recent Developments
11.2 FASTest
11.2.1 FASTest Corporation Information
11.2.2 FASTest Business Overview
11.2.3 FASTest Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.2.4 FASTest Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 FASTest Giardia Diagnostic Test Kit Sales by Product in 2024
11.2.6 FASTest Giardia Diagnostic Test Kit Sales by Application in 2024
11.2.7 FASTest Giardia Diagnostic Test Kit Sales by Geographic Area in 2024
11.2.8 FASTest Giardia Diagnostic Test Kit SWOT Analysis
11.2.9 FASTest Recent Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Corporation Information
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.3.4 Cardinal Health Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Cardinal Health Giardia Diagnostic Test Kit Sales by Product in 2024
11.3.6 Cardinal Health Giardia Diagnostic Test Kit Sales by Application in 2024
11.3.7 Cardinal Health Giardia Diagnostic Test Kit Sales by Geographic Area in 2024
11.3.8 Cardinal Health Giardia Diagnostic Test Kit SWOT Analysis
11.3.9 Cardinal Health Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.4.4 Thermo Fisher Scientific Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific Giardia Diagnostic Test Kit Sales by Product in 2024
11.4.6 Thermo Fisher Scientific Giardia Diagnostic Test Kit Sales by Application in 2024
11.4.7 Thermo Fisher Scientific Giardia Diagnostic Test Kit Sales by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific Giardia Diagnostic Test Kit SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 Anigen
11.5.1 Anigen Corporation Information
11.5.2 Anigen Business Overview
11.5.3 Anigen Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.5.4 Anigen Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Anigen Giardia Diagnostic Test Kit Sales by Product in 2024
11.5.6 Anigen Giardia Diagnostic Test Kit Sales by Application in 2024
11.5.7 Anigen Giardia Diagnostic Test Kit Sales by Geographic Area in 2024
11.5.8 Anigen Giardia Diagnostic Test Kit SWOT Analysis
11.5.9 Anigen Recent Developments
11.6 ALLTEST
11.6.1 ALLTEST Corporation Information
11.6.2 ALLTEST Business Overview
11.6.3 ALLTEST Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.6.4 ALLTEST Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ALLTEST Recent Developments
11.7 Bioguard corporation
11.7.1 Bioguard corporation Corporation Information
11.7.2 Bioguard corporation Business Overview
11.7.3 Bioguard corporation Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.7.4 Bioguard corporation Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bioguard corporation Recent Developments
11.8 Bionote
11.8.1 Bionote Corporation Information
11.8.2 Bionote Business Overview
11.8.3 Bionote Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.8.4 Bionote Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Bionote Recent Developments
11.9 Coris BioConcept
11.9.1 Coris BioConcept Corporation Information
11.9.2 Coris BioConcept Business Overview
11.9.3 Coris BioConcept Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.9.4 Coris BioConcept Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Coris BioConcept Recent Developments
11.10 Equi
11.10.1 Equi Corporation Information
11.10.2 Equi Business Overview
11.10.3 Equi Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.10.4 Equi Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Equi Recent Developments
11.11 Fassisi GmbH
11.11.1 Fassisi GmbH Corporation Information
11.11.2 Fassisi GmbH Business Overview
11.11.3 Fassisi GmbH Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.11.4 Fassisi GmbH Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Fassisi GmbH Recent Developments
11.12 HWTA
11.12.1 HWTA Corporation Information
11.12.2 HWTA Business Overview
11.12.3 HWTA Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.12.4 HWTA Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 HWTA Recent Developments
11.13 Idexx Laboratories
11.13.1 Idexx Laboratories Corporation Information
11.13.2 Idexx Laboratories Business Overview
11.13.3 Idexx Laboratories Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.13.4 Idexx Laboratories Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Idexx Laboratories Recent Developments
11.14 MEGACOR Diagnostik
11.14.1 MEGACOR Diagnostik Corporation Information
11.14.2 MEGACOR Diagnostik Business Overview
11.14.3 MEGACOR Diagnostik Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.14.4 MEGACOR Diagnostik Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 MEGACOR Diagnostik Recent Developments
11.15 Nanjing Liming Bio-products Co., Ltd.
11.15.1 Nanjing Liming Bio-products Co., Ltd. Corporation Information
11.15.2 Nanjing Liming Bio-products Co., Ltd. Business Overview
11.15.3 Nanjing Liming Bio-products Co., Ltd. Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.15.4 Nanjing Liming Bio-products Co., Ltd. Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Nanjing Liming Bio-products Co., Ltd. Recent Developments
11.16 R-Biopharm AG
11.16.1 R-Biopharm AG Corporation Information
11.16.2 R-Biopharm AG Business Overview
11.16.3 R-Biopharm AG Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.16.4 R-Biopharm AG Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 R-Biopharm AG Recent Developments
11.17 VIDIA s.r.o
11.17.1 VIDIA s.r.o Corporation Information
11.17.2 VIDIA s.r.o Business Overview
11.17.3 VIDIA s.r.o Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.17.4 VIDIA s.r.o Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 VIDIA s.r.o Recent Developments
11.18 Wuhan J.H.Bio-Tech
11.18.1 Wuhan J.H.Bio-Tech Corporation Information
11.18.2 Wuhan J.H.Bio-Tech Business Overview
11.18.3 Wuhan J.H.Bio-Tech Giardia Diagnostic Test Kit Product Models, Descriptions and Specifications
11.18.4 Wuhan J.H.Bio-Tech Giardia Diagnostic Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Wuhan J.H.Bio-Tech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Giardia Diagnostic Test Kit Industry Chain
12.2 Giardia Diagnostic Test Kit Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Giardia Diagnostic Test Kit Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Giardia Diagnostic Test Kit Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Giardia Diagnostic Test Kit Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Giardia Diagnostic Test Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
FastEST
Cardinal Health
Anigen
ALLTEST
Bioguard Corporation
Bionote
Coris BioConcept
Fassisi
IDEXX Laboratories
MEGACOR Diagnostik
Nanjing Liming Bio-products Co., Ltd.
R-Biopharm AG
VIDIA s.r.o
Wuhan J.H.Bio-Tech
Equi
HWTA
List of Tables
 Table 1. Global Giardia Diagnostic Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Giardia Diagnostic Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Giardia Diagnostic Test Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Giardia Diagnostic Test Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Giardia Diagnostic Test Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Giardia Diagnostic Test Kit Sales by Region (2020-2025) & (Units)
 Table 8. Global Giardia Diagnostic Test Kit Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Giardia Diagnostic Test Kit Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Giardia Diagnostic Test Kit Sales Share by Manufacturers (2020-2025)
 Table 12. Global Giardia Diagnostic Test Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Giardia Diagnostic Test Kit Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Giardia Diagnostic Test Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giardia Diagnostic Test Kit as of 2024)
 Table 16. Global Giardia Diagnostic Test Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Giardia Diagnostic Test Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Giardia Diagnostic Test Kit Manufacturing Base and Headquarters
 Table 19. Global Giardia Diagnostic Test Kit Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Giardia Diagnostic Test Kit Sales by Type (2020-2025) & (Units)
 Table 23. Global Giardia Diagnostic Test Kit Sales by Type (2026-2031) & (Units)
 Table 24. Global Giardia Diagnostic Test Kit Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Giardia Diagnostic Test Kit Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Giardia Diagnostic Test Kit ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Giardia Diagnostic Test Kit Sales by Application (2020-2025) & (Units)
 Table 29. Global Giardia Diagnostic Test Kit Sales by Application (2026-2031) & (Units)
 Table 30. Giardia Diagnostic Test Kit High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Giardia Diagnostic Test Kit Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Giardia Diagnostic Test Kit Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Giardia Diagnostic Test Kit ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Giardia Diagnostic Test Kit Growth Accelerators and Market Barriers
 Table 37. North America Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Giardia Diagnostic Test Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Giardia Diagnostic Test Kit Growth Accelerators and Market Barriers
 Table 40. Europe Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Giardia Diagnostic Test Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Giardia Diagnostic Test Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Giardia Diagnostic Test Kit Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Giardia Diagnostic Test Kit Investment Opportunities and Key Challenges
 Table 47. Central and South America Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Giardia Diagnostic Test Kit Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Giardia Diagnostic Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Certest Biotec Corporation Information
 Table 51. Certest Biotec Description and Major Businesses
 Table 52. Certest Biotec Product Models, Descriptions and Specifications
 Table 53. Certest Biotec Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Certest Biotec Sales Value Proportion by Product in 2024
 Table 55. Certest Biotec Sales Value Proportion by Application in 2024
 Table 56. Certest Biotec Sales Value Proportion by Geographic Area in 2024
 Table 57. Certest Biotec Giardia Diagnostic Test Kit SWOT Analysis
 Table 58. Certest Biotec Recent Developments
 Table 59. FASTest Corporation Information
 Table 60. FASTest Description and Major Businesses
 Table 61. FASTest Product Models, Descriptions and Specifications
 Table 62. FASTest Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. FASTest Sales Value Proportion by Product in 2024
 Table 64. FASTest Sales Value Proportion by Application in 2024
 Table 65. FASTest Sales Value Proportion by Geographic Area in 2024
 Table 66. FASTest Giardia Diagnostic Test Kit SWOT Analysis
 Table 67. FASTest Recent Developments
 Table 68. Cardinal Health Corporation Information
 Table 69. Cardinal Health Description and Major Businesses
 Table 70. Cardinal Health Product Models, Descriptions and Specifications
 Table 71. Cardinal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Cardinal Health Sales Value Proportion by Product in 2024
 Table 73. Cardinal Health Sales Value Proportion by Application in 2024
 Table 74. Cardinal Health Sales Value Proportion by Geographic Area in 2024
 Table 75. Cardinal Health Giardia Diagnostic Test Kit SWOT Analysis
 Table 76. Cardinal Health Recent Developments
 Table 77. Thermo Fisher Scientific Corporation Information
 Table 78. Thermo Fisher Scientific Description and Major Businesses
 Table 79. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 80. Thermo Fisher Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 82. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 83. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 84. Thermo Fisher Scientific Giardia Diagnostic Test Kit SWOT Analysis
 Table 85. Thermo Fisher Scientific Recent Developments
 Table 86. Anigen Corporation Information
 Table 87. Anigen Description and Major Businesses
 Table 88. Anigen Product Models, Descriptions and Specifications
 Table 89. Anigen Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Anigen Sales Value Proportion by Product in 2024
 Table 91. Anigen Sales Value Proportion by Application in 2024
 Table 92. Anigen Sales Value Proportion by Geographic Area in 2024
 Table 93. Anigen Giardia Diagnostic Test Kit SWOT Analysis
 Table 94. Anigen Recent Developments
 Table 95. ALLTEST Corporation Information
 Table 96. ALLTEST Description and Major Businesses
 Table 97. ALLTEST Product Models, Descriptions and Specifications
 Table 98. ALLTEST Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. ALLTEST Recent Developments
 Table 100. Bioguard corporation Corporation Information
 Table 101. Bioguard corporation Description and Major Businesses
 Table 102. Bioguard corporation Product Models, Descriptions and Specifications
 Table 103. Bioguard corporation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Bioguard corporation Recent Developments
 Table 105. Bionote Corporation Information
 Table 106. Bionote Description and Major Businesses
 Table 107. Bionote Product Models, Descriptions and Specifications
 Table 108. Bionote Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Bionote Recent Developments
 Table 110. Coris BioConcept Corporation Information
 Table 111. Coris BioConcept Description and Major Businesses
 Table 112. Coris BioConcept Product Models, Descriptions and Specifications
 Table 113. Coris BioConcept Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Coris BioConcept Recent Developments
 Table 115. Equi Corporation Information
 Table 116. Equi Description and Major Businesses
 Table 117. Equi Product Models, Descriptions and Specifications
 Table 118. Equi Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Equi Recent Developments
 Table 120. Fassisi GmbH Corporation Information
 Table 121. Fassisi GmbH Description and Major Businesses
 Table 122. Fassisi GmbH Product Models, Descriptions and Specifications
 Table 123. Fassisi GmbH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Fassisi GmbH Recent Developments
 Table 125. HWTA Corporation Information
 Table 126. HWTA Description and Major Businesses
 Table 127. HWTA Product Models, Descriptions and Specifications
 Table 128. HWTA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. HWTA Recent Developments
 Table 130. Idexx Laboratories Corporation Information
 Table 131. Idexx Laboratories Description and Major Businesses
 Table 132. Idexx Laboratories Product Models, Descriptions and Specifications
 Table 133. Idexx Laboratories Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Idexx Laboratories Recent Developments
 Table 135. MEGACOR Diagnostik Corporation Information
 Table 136. MEGACOR Diagnostik Description and Major Businesses
 Table 137. MEGACOR Diagnostik Product Models, Descriptions and Specifications
 Table 138. MEGACOR Diagnostik Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. MEGACOR Diagnostik Recent Developments
 Table 140. Nanjing Liming Bio-products Co., Ltd. Corporation Information
 Table 141. Nanjing Liming Bio-products Co., Ltd. Description and Major Businesses
 Table 142. Nanjing Liming Bio-products Co., Ltd. Product Models, Descriptions and Specifications
 Table 143. Nanjing Liming Bio-products Co., Ltd. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Nanjing Liming Bio-products Co., Ltd. Recent Developments
 Table 145. R-Biopharm AG Corporation Information
 Table 146. R-Biopharm AG Description and Major Businesses
 Table 147. R-Biopharm AG Product Models, Descriptions and Specifications
 Table 148. R-Biopharm AG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. R-Biopharm AG Recent Developments
 Table 150. VIDIA s.r.o Corporation Information
 Table 151. VIDIA s.r.o Description and Major Businesses
 Table 152. VIDIA s.r.o Product Models, Descriptions and Specifications
 Table 153. VIDIA s.r.o Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. VIDIA s.r.o Recent Developments
 Table 155. Wuhan J.H.Bio-Tech Corporation Information
 Table 156. Wuhan J.H.Bio-Tech Description and Major Businesses
 Table 157. Wuhan J.H.Bio-Tech Product Models, Descriptions and Specifications
 Table 158. Wuhan J.H.Bio-Tech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Wuhan J.H.Bio-Tech Recent Developments
 Table 160. Key Raw Materials Distribution
 Table 161. Raw Materials Key Suppliers
 Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 163. Milestones in Production Technology Evolution
 Table 164. Distributors List
 Table 165. Market Trends and Market Evolution
 Table 166. Market Drivers and Opportunities
 Table 167. Market Challenges, Risks, and Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. Giardia Diagnostic Test Kit Product Picture
 Figure 2. Global Giardia Diagnostic Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. For Human Product Picture
 Figure 4. For Pets (Cats Or Dogs) Product Picture
 Figure 5. Global Giardia Diagnostic Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pet Hospital
 Figure 7. Pharmacy
 Figure 8. Giardia Diagnostic Test Kit Report Years Considered
 Figure 9. Global Giardia Diagnostic Test Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Giardia Diagnostic Test Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Giardia Diagnostic Test Kit Revenue Market Share by Region (2020-2031)
 Figure 13. Global Giardia Diagnostic Test Kit Sales (2020-2031) & (Units)
 Figure 14. Global Giardia Diagnostic Test Kit Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Giardia Diagnostic Test Kit Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Giardia Diagnostic Test Kit Sales Volume Market Share in 2024
 Figure 17. Global Giardia Diagnostic Test Kit Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. For Human Revenue Market Share by Manufacturer in 2024
 Figure 20. For Pets (Cats Or Dogs) Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Giardia Diagnostic Test Kit Sales Market Share by Type (2020-2031)
 Figure 22. Global Giardia Diagnostic Test Kit Revenue Market Share by Type (2020-2031)
 Figure 23. Global Giardia Diagnostic Test Kit Sales Market Share by Application (2020-2031)
 Figure 24. Global Giardia Diagnostic Test Kit Revenue Market Share by Application (2020-2031)
 Figure 25. North America Giardia Diagnostic Test Kit Sales YoY (2020-2031) & (Units)
 Figure 26. North America Giardia Diagnostic Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Giardia Diagnostic Test Kit Sales Revenue (US$ Million) in 2024
 Figure 28. North America Giardia Diagnostic Test Kit Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Giardia Diagnostic Test Kit Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Giardia Diagnostic Test Kit Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Giardia Diagnostic Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Giardia Diagnostic Test Kit Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Giardia Diagnostic Test Kit Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Giardia Diagnostic Test Kit Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 43. France Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Giardia Diagnostic Test Kit Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Giardia Diagnostic Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Giardia Diagnostic Test Kit Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Giardia Diagnostic Test Kit Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Giardia Diagnostic Test Kit Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 58. India Giardia Diagnostic Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Giardia Diagnostic Test Kit Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Giardia Diagnostic Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Giardia Diagnostic Test Kit Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Giardia Diagnostic Test Kit Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Giardia Diagnostic Test Kit Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Giardia Diagnostic Test Kit Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Giardia Diagnostic Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Giardia Diagnostic Test Kit Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Giardia Diagnostic Test Kit Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Giardia Diagnostic Test Kit Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Giardia Diagnostic Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Giardia Diagnostic Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 79. Giardia Diagnostic Test Kit Industry Chain Mapping
 Figure 80. Regional Giardia Diagnostic Test Kit Manufacturing Base Distribution (%)
 Figure 81. Global Giardia Diagnostic Test Kit Production Market Share by Region (2020-2031)
 Figure 82. Giardia Diagnostic Test Kit Production Process
 Figure 83. Regional Giardia Diagnostic Test Kit Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Giardia Test Kit Market Research Report 2024
Global Stool Test Kit Market Research Report 2024
Global Animal Disease Diagnostic Kits Market Research Report 2024
Global Parasite Detection Kit Market Research Report 2024
Global Swine Diagnostic Test Kit Market Research Report 2024
Global Pet Disease Diagnostic Test Kit Market Research Report 2024
Viral Diagnostic Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enteric Pathogen Test Kits Market Research Report 2025
Global Cattle Diagnostic Kit Market Research Report 2024
Global Poultry Diagnostics Kits Market Research Report 2024
Global Veterinary Diagnostic PCR Kit Market Research Report 2024
Global Aquaculture Diagnostic Kits Market Research Report 2024
Rapid Diagnostic Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Diagnostic Test Kits Market Research Report 2025
Global Norovirus Test Kit Market Research Report 2024
Global Medical Diagnostic Testing Kit Market Research Report 2024
Global Diarrhea Pathogen Multiplex Detection Kits Market Research Report 2024
Global Giardia ELISA Test Kit Market Research Report 2024
Global STD Testing Kits Market Research Report 2024
Global Giardia ELISA Kits Market Research Report 2024

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37D12504
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Autonomous Ultrasound Guidance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9D20268
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Radiation Therapy Contouring Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Q19843
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Biliary and Pancreatic Drainage Stent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27T19786
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions